Thomas Lee, Fundstrat Global Advisors Managing Partner & Head of Research, discusses the search for yield and gives his top picks.
CNBC's Meg Tirrell reports the latest of what Pfizer CEO Ian Read has to say on biotech valuations, the election and more. The “Fast Money Halftime Report” traders and Stephanie Link, TIAA Global Asset Management, weigh in.
John Lechleiter, Eli Lilly CEO, and David Ricks, incoming Eli Lilly CEO, dicusses the need to make changes around the Affordable Care Act.
John Lechleiter, Eli Lilly CEO, and David Ricks, incoming Eli Lilly CEO talk about Eli Lilly's succession plan as the company launches a new chapter in its history.